Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Kalpadakis

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Expert Review of Hematology|June 15, 2011
Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemiaCharalampos Pontikoglou, Christina Kalpadakis, Helen A Papadaki
International Journal of Laboratory Hematology|May 20, 2026
How I Investigate Borderline Prolonged aPTT: An Integrated Laboratory Approach to Mixing Studies and Factor AnalysisNikolaos Androulakis, Eleni Nioti, Antonios Dilintas, et al.
Journal of Clinical Medicine|August 27, 2021
Decoding the Myeloid-Derived Suppressor Cells in Lymphoid MalignanciesIosif Papafragkos, Efrosyni Markaki, Christina Kalpadakis, et al.
Best Practice & Research. Clinical Haematology|March 15, 2017
Treatment of splenic marginal zone lymphomaChristina Kalpadakis, Gerassimos A Pangalis, Maria K Angelopoulou, et al.
Leukemia & Lymphoma|September 21, 2013
Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?Christina Kalpadakis, Gerassimos A Pangalis, Theodoros P Vassilakopoulos, et al.
Best Practice & Research. Clinical Haematology|February 18, 2018
Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?Christina Kalpadakis, Gerassimos A Pangalis, Maria K Angelopoulou, et al.
Leukemia & Lymphoma|September 6, 2013
Nodal marginal zone lymphomaMaria K Angelopoulou, Christina Kalpadakis, Gerassimos A Pangalis, et al.
Leukemia Research|November 20, 2010
Evaluation of TET2 deletions in myeloid disorders: a fluorescence in situ hybridization analysis of 109 casesMirjam Klaus, Anna Psaraki, Semeli Mastrodemou, et al.
International Journal of Sports Medicine|July 7, 2026
Leukocyte Morphology Changes during Preseason in Elite Soccer Players: A Pilot StudyNikolaos Androulakis, Eleni Nioti, Antonios Dilintas, et al.
Leukemia Research|August 7, 2010
Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on megakaryopoiesis of patients with lower risk myelodysplastic syndromeIrene Mavroudi, Katerina Pyrovolaki, Konstantia Pavlaki, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Expert Review of Hematology|June 15, 2011
Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemiaCharalampos Pontikoglou, Christina Kalpadakis, Helen A Papadaki
International Journal of Laboratory Hematology|May 20, 2026
How I Investigate Borderline Prolonged aPTT: An Integrated Laboratory Approach to Mixing Studies and Factor AnalysisNikolaos Androulakis, Eleni Nioti, Antonios Dilintas, et al.
Journal of Clinical Medicine|August 27, 2021
Decoding the Myeloid-Derived Suppressor Cells in Lymphoid MalignanciesIosif Papafragkos, Efrosyni Markaki, Christina Kalpadakis, et al.
Best Practice & Research. Clinical Haematology|March 15, 2017
Treatment of splenic marginal zone lymphomaChristina Kalpadakis, Gerassimos A Pangalis, Maria K Angelopoulou, et al.
Leukemia & Lymphoma|September 21, 2013
Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?Christina Kalpadakis, Gerassimos A Pangalis, Theodoros P Vassilakopoulos, et al.
Best Practice & Research. Clinical Haematology|February 18, 2018
Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?Christina Kalpadakis, Gerassimos A Pangalis, Maria K Angelopoulou, et al.
Leukemia & Lymphoma|September 6, 2013
Nodal marginal zone lymphomaMaria K Angelopoulou, Christina Kalpadakis, Gerassimos A Pangalis, et al.
Leukemia Research|November 20, 2010
Evaluation of TET2 deletions in myeloid disorders: a fluorescence in situ hybridization analysis of 109 casesMirjam Klaus, Anna Psaraki, Semeli Mastrodemou, et al.
International Journal of Sports Medicine|July 7, 2026
Leukocyte Morphology Changes during Preseason in Elite Soccer Players: A Pilot StudyNikolaos Androulakis, Eleni Nioti, Antonios Dilintas, et al.
Leukemia Research|August 7, 2010
Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on megakaryopoiesis of patients with lower risk myelodysplastic syndromeIrene Mavroudi, Katerina Pyrovolaki, Konstantia Pavlaki, et al.
Pageof 6